Welcome to today's Medical News Today News Alert containing today's medical news headlines for your chosen categories. You will only receive these alerts when new news is available for your chosen categories.
To unsubscribe from our news alerts, or to alter any of your subscription details (name,e-mail address etc) please see
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
----------------------------------------------
** BREAST CANCER News **
Sexual Intimacy And Breast Cancer Survivors: New Research
http://www.medicalnewstoday.com/articles/128794.php
An Indiana University study found that young, female breast cancer survivors often suffer from sexual and intimate relationship issues and are interested in using sexual enhancement products to treat these problems.
DxS Expand Their Portfolio Of Cancer Mutation Products, With The Launch Of A PI3K Mutation Detection Kit
http://www.medicalnewstoday.com/articles/128790.php
DxS, a personalised medicine company and market leaders in the provision of companion diagnostics are pleased to announce the addition of a PI3K Mutation Detection Kit to their portfolio of oncogene mutation products.
Breast Cancer - Diagenic Announces Launch Of First Breast Cancer Gene-Expression Blood Test
http://www.medicalnewstoday.com/articles/128764.php
DiaGenic ASA (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI) today announced the launch of BCtect(TM), a blood-based test for early detection of breast cancer. The test searches for a unique gene expression signature identified by DiaGenic using a custom TaqMan(R) Array manufactured for DiaGenic by Applied Biosystems.
----------------------------------------------
** CANCER / ONCOLOGY News **
Tumors Grow Faster Without Blood-Supply Promoting Molecule
http://www.medicalnewstoday.com/articles/128797.php
Dense networks of blood vessels thought to spur cancer's growth could actually hinder rather than promote tumor progression, according to a new study at the University of California, San Diego.
DxS Expand Their Portfolio Of Cancer Mutation Products, With The Launch Of A PI3K Mutation Detection Kit
http://www.medicalnewstoday.com/articles/128790.php
DxS, a personalised medicine company and market leaders in the provision of companion diagnostics are pleased to announce the addition of a PI3K Mutation Detection Kit to their portfolio of oncogene mutation products.
Robotic Assisted Laparoscopic Partial Nephrectomy For Suspected Renal Cell Carcinoma
http://www.medicalnewstoday.com/articles/128767.php
UroToday.com - Our single center study on robotic partial nephrectomy represents one of the largest series in the world. The study, which shows results comparable, if not better, than most laparoscopic series, is significant for the relatively short ischemic times and excellent pathological outcomes.
Breast Cancer - Diagenic Announces Launch Of First Breast Cancer Gene-Expression Blood Test
http://www.medicalnewstoday.com/articles/128764.php
DiaGenic ASA (OSL: DIAG) and Applied Biosystems Inc. (NYSE: ABI) today announced the launch of BCtect(TM), a blood-based test for early detection of breast cancer. The test searches for a unique gene expression signature identified by DiaGenic using a custom TaqMan(R) Array manufactured for DiaGenic by Applied Biosystems.
Major Advance In Cancer Radiotherapy
http://www.medicalnewstoday.com/articles/128694.php
Radical improvements in outcome for many cancer sufferers are in prospect following one of the most significant advances in radiotherapy since x-rays were first used to treat a tumour in 1904.
----------------------------------------------
** CERVICAL CANCER / HPV VACCINE News **
No news for this category today.
----------------------------------------------
** COLORECTAL CANCER News **
Huge Variation In Cost Of Treating Colorectal Cancer
http://www.medicalnewstoday.com/articles/128702.php
The cost of treating colorectal cancer varies widely, with newer, life-extending therapies sometimes costing tens of thousands of dollars more than older agents, according to a study led by a team of researchers in the Duke Comprehensive Cancer Center.
Studies Examine Whether Information About Colon Cancer Discourages Blacks From Screening; Job Stress Among Filipino Immigrants; More
http://www.medicalnewstoday.com/articles/128685.php
"<a href="http://cebp.aacrjournals.org/cgi/content/abstract/17/11/2946" target="_new">Unintended Effects of Emphasizing Disparities in Cancer Communication to African-Americans</a>," <cite>Cancer Epidemiology, Biomarkers & Prevention</cite>: For the study, researcher Robert Nicholson, an assistant professor in the Department of Neurology and Psychiatry at the St.
----------------------------------------------
** LUNG CANCER News **
No news for this category today.
----------------------------------------------
** LYMPHOMA / LEUKEMIA News **
National Gala Raises Over $1.15 Million For Lymphoma-Focused Research - Guests Vote To Eradicate Lymphoma
http://www.medicalnewstoday.com/articles/128775.php
Over 520 guests reached into their pockets to the tune of over $1.15 million and cast their vote for increased funding for lymphoma-focused research at Vote For A Cure: the Lymphoma Research Foundation's (LRF) 2008 National Gala held on October 6 at the New York Marriot Marquis.
----------------------------------------------
** PROSTATE / PROSTATE CANCER News **
European Urology: Relationship Between Prostate Information And LUTS Evident
http://www.medicalnewstoday.com/articles/128819.php
In the December issue of European Urology, Dr. Curtis Nickel and associates report on the evidence of a relationship between prostate inflammation and lower urinary tract symptoms (LUTS) in men enrolled in the REDUCE trial .
Circulating Tumor Cells Predict Survival Benefit From Treatment In Metastatic Castration-Resistant Prostate Cancer
http://www.medicalnewstoday.com/articles/128802.php
UroToday.com - In the October 1, 2008 issue of <i>Clinical Cancer Research</i>, Dr. Johann de Bono and colleagues presented exciting data indicating that circulating tumor cells (CTC) predict overall survival (OS) in patients with castration-resistant prostate cancer (CRPC).
Eight Years' Experience With High-Intensity Focused Ultrasonography For Treatment Of Localized Prostate Cancer
http://www.medicalnewstoday.com/articles/128783.php
BERKELEY, CA (UroToday.com) - High-intensity focused ultrasonography (HIFU) is an approach to the treatment of prostate cancer (CaP). While not FDA approved in the US, it is approved and gaining popularity in many countries.
-------------------------------------------------------------
You are receiving this news alert e-mail because you subscribed via an online form on our web site. If you wish to unsubscribe, please visit
http://www.medicalnewstoday.com/newsalerts.php?changemydetails=y .
No comments:
Post a Comment